---
document_datetime: 2025-11-23 13:11:22
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/fluenz-0.html
document_name: fluenz-0.html
version: success
processing_time: 0.0902323
conversion_datetime: 2025-12-25 03:02:34.853445
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Fluenz

[RSS](/en/individual-human-medicine.xml/66132)

##### Withdrawn

This medicine's authorisation has been withdrawn

influenza vaccine (live attenuated, nasal)

Medicine

Human

Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [More information on Fluenz](#related-medicines)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 1st October 2014, the European Commission withdrew the marketing authorisation for Fluenz (influenza vaccine (live attenuated, nasal)) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, MedImmune LLC, which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Fluenz was granted marketing authorisation in the EU on 27 January 2011 for the prevention of influenza (flu). The marketing authorisation was initially valid for a 5-year period. The product had not been marketed in the EU since the 2013-14 influenza season.

Fluenz is a trivalent (containing three strains of flu virus) influenza vaccine. It will be replaced by Fluenz Tetra, a tetravalent (four-strain) influenza vaccine which is authorised in the EU since 04 December 2013 for the same indication as Fluenz, i.e. prevention of influenza. MedImmune LLC will maintain the marketing authorisation for Fluenz Tetra.

The European Public Assessment Report (EPAR) for Fluenz is updated accordingly to reflect the fact that the marketing authorisation is no longer valid.

Fluenz  : EPAR - Summary for the public

Reference Number: EMA/CHMP/682933/2010

English (EN) (548.88 KB - PDF)

**First published:** 17/03/2011

**Last updated:** 03/12/2014

[View](/en/documents/overview/fluenz-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-780)

български (BG) (634.56 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/bg/documents/overview/fluenz-epar-summary-public_bg.pdf)

español (ES) (544.08 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/es/documents/overview/fluenz-epar-summary-public_es.pdf)

čeština (CS) (615.17 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/cs/documents/overview/fluenz-epar-summary-public_cs.pdf)

dansk (DA) (543.96 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/da/documents/overview/fluenz-epar-summary-public_da.pdf)

Deutsch (DE) (568.61 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/de/documents/overview/fluenz-epar-summary-public_de.pdf)

eesti keel (ET) (542.37 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/et/documents/overview/fluenz-epar-summary-public_et.pdf)

ελληνικά (EL) (632.02 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/el/documents/overview/fluenz-epar-summary-public_el.pdf)

français (FR) (545.82 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/fr/documents/overview/fluenz-epar-summary-public_fr.pdf)

hrvatski (HR) (561.87 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/hr/documents/overview/fluenz-epar-summary-public_hr.pdf)

italiano (IT) (542.55 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/it/documents/overview/fluenz-epar-summary-public_it.pdf)

latviešu valoda (LV) (610.4 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/lv/documents/overview/fluenz-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (571.18 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/lt/documents/overview/fluenz-epar-summary-public_lt.pdf)

magyar (HU) (604.94 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/hu/documents/overview/fluenz-epar-summary-public_hu.pdf)

Malti (MT) (614.1 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/mt/documents/overview/fluenz-epar-summary-public_mt.pdf)

Nederlands (NL) (542.83 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/nl/documents/overview/fluenz-epar-summary-public_nl.pdf)

polski (PL) (610.37 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/pl/documents/overview/fluenz-epar-summary-public_pl.pdf)

português (PT) (544 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/pt/documents/overview/fluenz-epar-summary-public_pt.pdf)

română (RO) (570.69 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/ro/documents/overview/fluenz-epar-summary-public_ro.pdf)

slovenčina (SK) (612.04 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/sk/documents/overview/fluenz-epar-summary-public_sk.pdf)

slovenščina (SL) (600.87 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/sl/documents/overview/fluenz-epar-summary-public_sl.pdf)

Suomi (FI) (542.36 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/fi/documents/overview/fluenz-epar-summary-public_fi.pdf)

svenska (SV) (543.29 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/sv/documents/overview/fluenz-epar-summary-public_sv.pdf)

## Product information

**Latest procedure affecting product information:** IAIN/0056 21/10/2013

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Fluenz  : EPAR - All Authorised presentations

English (EN) (218.56 KB - PDF)

**First published:** 17/03/2011

**Last updated:** 03/12/2014

[View](/en/documents/all-authorised-presentations/fluenz-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-631)

български (BG) (406.06 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/bg/documents/all-authorised-presentations/fluenz-epar-all-authorised-presentations_bg.pdf)

español (ES) (141.61 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/es/documents/all-authorised-presentations/fluenz-epar-all-authorised-presentations_es.pdf)

čeština (CS) (269.06 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/cs/documents/all-authorised-presentations/fluenz-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (209.01 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/da/documents/all-authorised-presentations/fluenz-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (143.06 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/de/documents/all-authorised-presentations/fluenz-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (141.19 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/et/documents/all-authorised-presentations/fluenz-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (344.88 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/el/documents/all-authorised-presentations/fluenz-epar-all-authorised-presentations_el.pdf)

français (FR) (260.48 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/fr/documents/all-authorised-presentations/fluenz-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (262.79 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/hr/documents/all-authorised-presentations/fluenz-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (142.28 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/is/documents/all-authorised-presentations/fluenz-epar-all-authorised-presentations_is.pdf)

italiano (IT) (207.14 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/it/documents/all-authorised-presentations/fluenz-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (269.21 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/lv/documents/all-authorised-presentations/fluenz-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (389.13 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/lt/documents/all-authorised-presentations/fluenz-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (270.05 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/hu/documents/all-authorised-presentations/fluenz-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (273.52 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/mt/documents/all-authorised-presentations/fluenz-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (184.71 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/nl/documents/all-authorised-presentations/fluenz-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (141.13 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/no/documents/all-authorised-presentations/fluenz-epar-all-authorised-presentations_no.pdf)

polski (PL) (271.09 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/pl/documents/all-authorised-presentations/fluenz-epar-all-authorised-presentations_pl.pdf)

português (PT) (141.02 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/pt/documents/all-authorised-presentations/fluenz-epar-all-authorised-presentations_pt.pdf)

română (RO) (261.14 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/ro/documents/all-authorised-presentations/fluenz-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (270.45 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/sk/documents/all-authorised-presentations/fluenz-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (265.91 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/sl/documents/all-authorised-presentations/fluenz-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (208.52 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/fi/documents/all-authorised-presentations/fluenz-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (141.5 KB - PDF)

**First published:**

17/03/2011

**Last updated:**

03/12/2014

[View](/sv/documents/all-authorised-presentations/fluenz-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Fluenz Active substance reassortant influenza virus (live attenuated) of the following strains:A/California/7/2009 (H1N1)pdm09 like strain, A/Victoria/361/2011 (H3N2) like strain, B/Massachusetts/2/2012 like strain International non-proprietary name (INN) or common name influenza vaccine (live attenuated, nasal) Therapeutic area (MeSH)

- Influenza, Human
- Immunization

Anatomical therapeutic chemical (ATC) code J07BB03

### Pharmacotherapeutic group

Vaccines

### Therapeutic indication

Prophylaxis of influenza in individuals 24 months to less than 18 years of age.

The use of Fluenz should be based on official recommendations.

## Authorisation details

EMA product number EMEA/H/C/001101 Marketing authorisation holder

MedImmune LLC

Lagelandseweg 78

Marketing authorisation issued 27/01/2011 Withdrawal of marketing authorisation 01/10/2014 Revision 4

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Fluenz  : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (329.15 KB - PDF)

**First published:** 27/11/2012

**Last updated:** 03/12/2014

[View](/en/documents/procedural-steps-after/fluenz-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Fluenz-H-C-1101-P46-27 : EPAR - Assessment Report

Adopted

Reference Number: EMA/649861/2014

English (EN) (1.5 MB - PDF)

**First published:** 03/12/2014

**Last updated:** 03/12/2014

[View](/en/documents/variation-report/fluenz-h-c-1101-p46-27-epar-assessment-report_en.pdf)

Fluenz-H-C-1101-P46-28.1 : EPAR - Assessment Report

Adopted

Reference Number: EMA/649874/2014

English (EN) (565.58 KB - PDF)

**First published:** 03/12/2014

**Last updated:** 03/12/2014

[View](/en/documents/variation-report/fluenz-h-c-1101-p46-281-epar-assessment-report_en.pdf)

## Initial marketing authorisation documents

Fluenz  : EPAR - Public assessment report

Adopted

English (EN) (2.15 MB - PDF)

**First published:** 17/03/2011

**Last updated:** 03/12/2014

[View](/en/documents/assessment-report/fluenz-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Fluenz

Adopted

Reference Number: EMA/CHMP/503333/2010

English (EN) (270.9 KB - PDF)

**First published:** 22/10/2010

**Last updated:** 03/12/2014

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-fluenz_en.pdf)

#### More information on Fluenz

- [EMEA-000249-PIP01-10 - paediatric investigation plan](/en/medicines/human/paediatric-investigation-plans/emea-000249-pip01-10)

**This page was last updated on** 03/12/2014

## Share this page

[Back to top](#main-content)